[HTML][HTML] Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
X Zhou, K Shi, Y Hao, C Yang, R Zha, C Yi… - Asian journal of …, 2020 - Elsevier
Oral tyrosine kinase inhibitors (TKIs) against epidermal growth factor receptor (EGFR) family
have been introduced into the clinic to treat human malignancies for decades. Despite …
have been introduced into the clinic to treat human malignancies for decades. Despite …
Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy.
X Zhou, K Shi, Y Hao, C Yang, R Zha… - Asian Journal of …, 2020 - search.ebscohost.com
Oral tyrosine kinase inhibitors (TKIs) against epidermal growth factor receptor (EGFR) family
have been introduced into the clinic to treat human malignancies for decades. Despite …
have been introduced into the clinic to treat human malignancies for decades. Despite …
[PDF][PDF] Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
X Zhou, K Shi, Y Hao, C Yang, R Zha… - Asian Journal of …, 2020 - scienceopen.com
abstract Oral tyrosine kinase inhibitors (TKIs) against epidermal growth factor receptor
(EGFR) family have been introduced into the clinic to treat human malignancies for decades …
(EGFR) family have been introduced into the clinic to treat human malignancies for decades …
Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy.
X Zhou, K Shi, Y Hao, C Yang, R Zha, C Yi… - Asian Journal of …, 2019 - europepmc.org
Oral tyrosine kinase inhibitors (TKIs) against epidermal growth factor receptor (EGFR) family
have been introduced into the clinic to treat human malignancies for decades. Despite …
have been introduced into the clinic to treat human malignancies for decades. Despite …
Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
X Zhou, K Shi, Y Hao, C Yang… - Asian journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Oral tyrosine kinase inhibitors (TKIs) against epidermal growth factor receptor (EGFR) family
have been introduced into the clinic to treat human malignancies for decades. Despite …
have been introduced into the clinic to treat human malignancies for decades. Despite …
[HTML][HTML] Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
X Zhou, K Shi, Y Hao, C Yang, R Zha… - Asian Journal of …, 2020 - ncbi.nlm.nih.gov
Oral tyrosine kinase inhibitors (TKIs) against epidermal growth factor receptor (EGFR) family
have been introduced into the clinic to treat human malignancies for decades. Despite …
have been introduced into the clinic to treat human malignancies for decades. Despite …
[引用][C] Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
X Zhou, K Shi, Y Hao, C Yang, R Zha, C Yi… - Asian Journal of …, 2020 - osti.gov